Edition:
United States

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

2.33USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
55,484
52-wk High
$2.44
52-wk Low
$0.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
FY 2015 Dec '15 0.00 -0.831
Sep '15 0.00 -0.863
Jun '15 0.00 -0.897
Mar '15 0.00 -1.271
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 19.50
Earnings (per share)
Quarter Ending Dec-17 1 -0.24 -0.24 -0.24 -0.27
Year Ending Dec-17 1 -1.18 -1.18 -1.18 -1.44
Year Ending Dec-18 1 -0.98 -0.98 -0.98 -1.68
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. -- 277.36 45.22
P/E Low - Last 5 Yrs. -- 92.80 24.21
Beta -- 0.82 0.91
Price to Sales (TTM) -- 117.72 5.89
Price to Book (MRQ) 8.17 21.83 5.66
Price to Tangible Book (MRQ) 5.28 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 73.30 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago -- 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 28.40 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago 37.07 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 6.14 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.00 17.10 19.35
Interest Coverage (TTM) -- -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -219.33 15.51
Operating Margin (TTM) -- -637.28 6.68
Operating Margin - 5 Yr. Avg. -- -236.27 10.99
Pre-Tax Margin (TTM) -- -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -- -236.41 11.40
Net Profit Margin (TTM) -- -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -- -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,870,754 851,754,569
Net Income/Employee (TTM) -- -1,731,043 99,535,212
Receivable Turnover (TTM) -- 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -119.65 -9.33 11.32
Return on Assets - 5 Yr. Avg. -- 0.11 12.28
Return on Investment (TTM) -145.20 -11.61 14.44
Return on Investment - 5 Yr. Avg. -- 3.32 16.08
Return on Equity (TTM) -226.21 -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 58.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.98%
# of Holders: 26
Total Shares Held: 30,175,921
3 Mo. Net Change: 10,919,998
# New Positions: 7
# Closed Positions: 6
# Increased Positions: 12
# Reduced Positions: 9
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.